Skip to main content
. Author manuscript; available in PMC: 2021 Jul 1.
Published in final edited form as: Sleep Med. 2020 Feb 5;71:141–148. doi: 10.1016/j.sleep.2020.01.024

Table 2.

Average ± SD of total activity counts/1000, minutes resting and number of rest periods for the each of the 3 hours after each treatment – last 3 hours of the active period for the BXD40f on an ID diet.

1st hour 2nd hour 3rd hour
Treatment Activity/1000 Mins rest # rest periods Activity/1000 Mins rest # rest periods Activity/1000 Mins rest # rest periods
Saline 3.8 ±1.1 0.0 ± 0 0.0 ± 0 2.5 ± 2.2 4.3 ±5.7 0.4 ± 0.5 1.4 ± 1.6 11.1 ± 9.4 1.4 ± 1.1
12.5 mg L-dopa 1.6 ±1.1**** 7.7 ± 8.3 * 1.0 ± 1.0 * 1.9 ± 1.2 3.4 ± 4.7 0.6 ± 0.8 1.7 ±1.5 12.0 ± 9.8 1.0 ± 0.8
25.0 mg L-dopa 1.5 ± 1.0*** 3.4 ±4.7* 0.4 ± 0.5* 0.6 ± 0.2* 6.0 ± 10.0 0.6 ± 1.0 0.9 ± 0.7 10.3 ± 8.3 1.3 ± 0.8
0.5 mg Quin 1.2 ± 0.8**** 18.9 ± 16.0** 1.6 ± 1.1*** 1.6 ±1.2 12.0 ± 9.8 1.4 ± 1.0* 1.7 ± 1.2 9.4 ± 12.0 0.7 ± 1.0
1.0 mg Quin 0.9 ± 0.7**** 18.9 ± 15.3** 1.6 ± 1.1** 0.5 ± 0.2* 16.3 ± 9.6* 1.7 ± 1.0* 1.0 ± 0.5 11.1 ± 4.1 1.3 ± 0.5

Significance for within subject t test compared to saline

****

p<0.001

***

p< 0.005

**

p< 0.01

*

p< 0.05

Activity counts: Sum for each animal of number of gross body movements in each 6-minute period detected by the G2 E-Mitter telemetry. Average and SD total activity determined for 6 animals on iron-sufficient diet and 7 on iron-deficient diet.